Q4 2025 Holdings
Filed 2026-02-17 | 116 holdings | $5.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CVS Health Corp(CVS) | COM | 126650100 | $17.5M | 220,000 | 0.3% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $18.4M | 602,944 | 0.3% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $19.2M | 108,000 | 0.3% |
| Grail Inc(GRAL) | COM | 384747101 | $20.3M | 237,342 | 0.4% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $20.4M | 673,923 | 0.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $20.5M | 259,545 | 0.4% |
| Orchestra Biomed Hldgs Inc(OBIO) | COM | 68572M106 | $21.3M | 5,127,256 | 0.4% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $21.7M | 4,185,632 | 0.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $21.8M | 124,000 | 0.4% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $23.7M | 848,900 | 0.4% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $24.6M | 12,594,211 | 0.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $24.7M | 3,162,529 | 0.4% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $25.3M | 6,314,452 | 0.5% |
| Axogen Inc(AXGN) | COM | 05463X106 | $25.7M | 784,140 | 0.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $27.2M | 148,900 | 0.5% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $27.9M | 266,287 | 0.5% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $28.0M | 825,890 | 0.5% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $28.3M | 12,050,000 | 0.5% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $28.9M | 170,000 | 0.5% |
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $30.7M | 1,136,206 | 0.5% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $31.8M | 1,784,393 | 0.6% |
| Penumbra Inc(PEN) | COM | 70975L107 | $34.4M | 110,529 | 0.6% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $35.1M | 449,290 | 0.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $35.8M | 450,743 | 0.6% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $36.5M | 165,131 | 0.7% |
| Omada Health Inc(OMDA) | COM | 68170A108 | $37.8M | 2,396,330 | 0.7% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $41.2M | 9,680,185 | 0.7% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $44.8M | 1,476,501 | 0.8% |
| Danaher Corporation(DHR) | COM | 235851102 | $45.8M | 200,000 | 0.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $47.0M | 331,050 | 0.8% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $48.5M | 1,179,098 | 0.9% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $49.8M | 87,919 | 0.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $50.7M | 1,994,890 | 0.9% |
| Repligen Corp(RGEN) | COM | 759916109 | $51.7M | 315,541 | 0.9% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $53.0M | 5,869,076 | 0.9% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $53.8M | 21,785,166 | 1.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $61.8M | 458,343 | 1.1% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $66.3M | 414,239 | 1.2% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $66.7M | 11,833,539 | 1.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $67.5M | 3,555,877 | 1.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $68.0M | 3,478,944 | 1.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $73.0M | 2,917,634 | 1.3% |
| Artivion Inc(AORT) | COM | 228903100 | $78.6M | 1,722,290 | 1.4% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $82.1M | 10,326,103 | 1.5% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $84.9M | 6,485,420 | 1.5% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $85.9M | 3,261,850 | 1.5% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $90.7M | 6,370,851 | 1.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $93.3M | 979,000 | 1.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $94.7M | 3,042,703 | 1.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $95.6M | 1,466,071 | 1.7% |